Katherine Marie Ottolini

Dr. Katherine Marie Ottolini


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2020 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
KOKatherine Marie Ottolini
Katherine Marie Ottolini
NANickie Andescavage
Nickie Andescavage
KKKushal Kapse
Kushal Kapse
MJMarni Jacobs
Marni Jacobs
CLCatherine Limperopoulos
Catherine Limperopoulos

1 March 2021 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
KOKatherine Marie Ottolini
Katherine Marie Ottolini
SBSudeepta K. Basu
Sudeepta K. Basu
NHNicole Herrera
Nicole Herrera
VGVedavalli Govindan
Vedavalli Govindan
SMSuleiman Mashat
Suleiman Mashat
AMAn N. Massaro
An N. Massaro

29 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
KOKatherine Marie Ottolini
Katherine Marie Ottolini
ESElizabeth Vinson Schulz
Elizabeth Vinson Schulz
CLCatherine Limperopoulos
Catherine Limperopoulos
NANickie Niforatos Andescavage
Nickie Niforatos Andescavage
Premature infants are born prior to a critical window of rapid placental nutrient transfer and fetal growth—particularly brain development—that occurs during the third trimester of pregnancy. Subsequently, a large proportion of preterm neonates experience extrauterine growth failure and associated neurodevelopmental impairments. Human milk (maternal or donor breast milk) is the recommended source of enteral nutrition for preterm infants, but requires additional fortification of macronutrient, micronutrient, and energy content to meet the nutritional demands of the preterm infant in attempts at replicating in utero nutrient accretion and growth rates. Traditional standardized fortification practices that add a fixed amount of multicomponent fortifier based on assumed breast milk composition do not take into account the considerable variations in breast milk content or individual neonatal metabolism. Emerging methods of individualized fortification—including targeted and adjusted fortification—show promise in improving postnatal growth and neurodevelopmental outcomes in preterm infants.

22 May 2024 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
ESElizabeth V. Schulz
Elizabeth V. Schulz
CDCaitlin M. Drumm
Caitlin M. Drumm
KOKatherine Marie Ottolini
Katherine Marie Ottolini

23 June 2025 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
SBSudeepta K. Basu
Sudeepta K. Basu
KOKatherine Marie Ottolini
Katherine Marie Ottolini
KKKushal J. Kapse
Kushal J. Kapse
JNJulius Ngwa
Julius Ngwa
SHSteve C. N. Hui
Steve C. N. Hui
CLCatherine Limperopoulos
Catherine Limperopoulos
Objectives The impact of crucial early parenteral nutrition on neurometabolism of the preterm brain remains unclear. This study characterizes the relationship of parenteral lipid and caloric intake with cerebellar neurometabolites. Methods Very premature infants [born ≤32-week gestational age (GA)] in a prospective observational cohort study underwent a proton magnetic resonance spectroscopy (1H-MRS) acquisition from a cerebellar voxel at term-age. Parenteral lipid and caloric intake (g/kg/d or kcal/kg/d) in the first 4 weeks of life were calculated by chart review. Results 48 preterm infants born at 28.3 ± 2.4 weeks GA underwent 1H-MRS at 38.9 ± 1.9 weeks postmenstrual age. Cerebellar N-acetylaspartate [NAA] positively correlated with 4-week parenteral lipid (Rho = 0.4, p = 0.005) and caloric (Rho = 0.3, p = 0.047) intake. Glutamate [Glx] demonstrated a positive trend. Adjusted for covariates, 4-week parenteral lipid intake was associated with higher NAA (B coefficient = 0.89, p = 0.003) and Glx (B = 1.72, p = 0.045). Conclusions Parenteral lipid intake is associated with higher cerebellar NAA and Glx concentrations, supporting brain development in preterm infants.

23 October 2026 in The Journal of Pediatrics
Verified
Journal Article
Open access
KOKatherine Marie Ottolini
Katherine Marie Ottolini
TWTameka T. Watson
Tameka T. Watson
SBSudeepta K. Basu
Sudeepta K. Basu
JCJenhao J. Cheng
Jenhao J. Cheng
KKKushal Kapse
Kushal Kapse
CLCatherine Limperopoulos
Catherine Limperopoulos
To identify the timing and clinical risk factors associated with somatic growth faltering (GF) in very preterm infants (VPI, born < 32 weeks' gestation) and explore the relationship with longitudinal brain growth throughout the extrauterine second and third trimesters. Observational cohort followed with serial growth anthropometrics and brain magnetic resonance imaging at approximately 4-week intervals through term corrected age. Multivariable logistic regression identified clinical covariates associated with GF. Generalized additive models, extended linear mixed models, and multivariable linear mixed models were applied to create trajectories of nutritional intake and weight and brain growth and compare term corrected brain volumes between VPI with and without GF. 118 VPI (68 GF, 50 no GF) underwent 333 magnetic resonance imaging studies (195 GF, 138 no GF). Those with GF were born younger (mean [SD] 27.4 [2.2] vs 28.3 [2.3] weeks, p=0.02) and experienced more clinical comorbidities. Poor weight gain in GF VPI began after 33 weeks corrected age and was associated with early systemic steroids (odds ratio [95% CI] 3.8 [1.2,14.8], P=0.03) and gastrointestinal surgery (odds ratio [95% CI] 7.8 [1.8,53.9], P=0.01). GF infants demonstrated significantly lower lipid, caloric, and maternal milk intake trajectories than non-GF infants. VPI with GF compared with no GF experienced slower volumetric brain growth after 37 weeks corrected age in nearly all brain regions. Term corrected cerebellar (β= -1.74 [-2.95,-0.52], p=0.01) and brainstem (β= -0.29 [-0.55,-0.04], p=0.02) volumes were lower in GF infants after adjusting for significant covariates. Brain growth is impaired during critical extrauterine periods in GF VPI, with a 4-week interval between the onset of weight faltering and subsequent brain growth deceleration that may represent an important window for clinical intervention.